Nymox Pharmaceutical Corporation
Nymox Pharmaceutical to Present at the Growth and Value Investor Conference
Published in Drug Week, February 29th, 2008
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced that the Company will present at the 2008 Growth & Value Investor Conference to be held in at the Westin Fort Lauderdale, Fort Lauderdale, FL on February 27 and 28. At the Conference, the Company's CEO, Paul Averback, MD, will provide an overview of the Company's recent progress in drug development. The Growth & Value Investor Conference is hosted by LDV Capital Management in cooperation with the Stock and Bond Club of South Florida and is expected to attract 1,000 to 1,500 investment professionals.
Nymox recently announced positive results from a prospective randomized Phase 2 trial of NX-1207, its drug in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2008-02-29)
More Articles from Drug Week
- Addiction Medicine
New findings show additional similarity between opiate and nicotine addiction - Drug Resistance
Novel approach strips staph of virulence - Drugs
UCSD research team identifies novel anticancer drug from the sea - Epilepsy
Drug doesn't help prevent migraine after all - Gene Chips
Gene chips used to distinguish ventilator-associated pneumonia from underlying critical illness - HIV/AIDS
HIV persists in the gut despite long-term HIV therapy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
